JP2012525416A5 - - Google Patents

Download PDF

Info

Publication number
JP2012525416A5
JP2012525416A5 JP2012508657A JP2012508657A JP2012525416A5 JP 2012525416 A5 JP2012525416 A5 JP 2012525416A5 JP 2012508657 A JP2012508657 A JP 2012508657A JP 2012508657 A JP2012508657 A JP 2012508657A JP 2012525416 A5 JP2012525416 A5 JP 2012525416A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012508657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012525416A (ja
JP5801794B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/032822 external-priority patent/WO2010127033A1/en
Publication of JP2012525416A publication Critical patent/JP2012525416A/ja
Publication of JP2012525416A5 publication Critical patent/JP2012525416A5/ja
Application granted granted Critical
Publication of JP5801794B2 publication Critical patent/JP5801794B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012508657A 2009-04-28 2010-04-28 カンナビジオールの製剤及びその使用方法 Expired - Fee Related JP5801794B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17346909P 2009-04-28 2009-04-28
US61/173,469 2009-04-28
PCT/US2010/032822 WO2010127033A1 (en) 2009-04-28 2010-04-28 Formulations of cannabidiol and methods of using the same

Publications (3)

Publication Number Publication Date
JP2012525416A JP2012525416A (ja) 2012-10-22
JP2012525416A5 true JP2012525416A5 (enExample) 2014-12-11
JP5801794B2 JP5801794B2 (ja) 2015-10-28

Family

ID=42246015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012508657A Expired - Fee Related JP5801794B2 (ja) 2009-04-28 2010-04-28 カンナビジオールの製剤及びその使用方法

Country Status (6)

Country Link
US (1) US20100273895A1 (enExample)
EP (1) EP2424525A1 (enExample)
JP (1) JP5801794B2 (enExample)
CA (1) CA2760460C (enExample)
MX (1) MX2011011514A (enExample)
WO (1) WO2010127033A1 (enExample)

Families Citing this family (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8784336B2 (en) 2005-08-24 2014-07-22 C. R. Bard, Inc. Stylet apparatuses and methods of manufacture
US7794407B2 (en) 2006-10-23 2010-09-14 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US9649048B2 (en) 2007-11-26 2017-05-16 C. R. Bard, Inc. Systems and methods for breaching a sterile field for intravascular placement of a catheter
US9521961B2 (en) 2007-11-26 2016-12-20 C. R. Bard, Inc. Systems and methods for guiding a medical instrument
US8849382B2 (en) 2007-11-26 2014-09-30 C. R. Bard, Inc. Apparatus and display methods relating to intravascular placement of a catheter
US8781555B2 (en) 2007-11-26 2014-07-15 C. R. Bard, Inc. System for placement of a catheter including a signal-generating stylet
US9456766B2 (en) 2007-11-26 2016-10-04 C. R. Bard, Inc. Apparatus for use with needle insertion guidance system
US10449330B2 (en) 2007-11-26 2019-10-22 C. R. Bard, Inc. Magnetic element-equipped needle assemblies
US10751509B2 (en) 2007-11-26 2020-08-25 C. R. Bard, Inc. Iconic representations for guidance of an indwelling medical device
US10524691B2 (en) 2007-11-26 2020-01-07 C. R. Bard, Inc. Needle assembly including an aligned magnetic element
CN103750858B (zh) 2007-11-26 2017-04-12 C·R·巴德股份有限公司 用于脉管系统内的导管放置的集成系统
US8478382B2 (en) 2008-02-11 2013-07-02 C. R. Bard, Inc. Systems and methods for positioning a catheter
US9901714B2 (en) 2008-08-22 2018-02-27 C. R. Bard, Inc. Catheter assembly including ECG sensor and magnetic assemblies
US8437833B2 (en) 2008-10-07 2013-05-07 Bard Access Systems, Inc. Percutaneous magnetic gastrostomy
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
US9445734B2 (en) 2009-06-12 2016-09-20 Bard Access Systems, Inc. Devices and methods for endovascular electrography
CN102802514B (zh) 2009-06-12 2015-12-02 巴德阿克塞斯系统股份有限公司 导管末端定位设备
EP2482719A4 (en) 2009-09-29 2016-03-09 Bard Inc C R THORNS FOR USE IN A DEVICE FOR THE INTRAVASCULAR POSITIONING OF A CATHETER
US11103213B2 (en) 2009-10-08 2021-08-31 C. R. Bard, Inc. Spacers for use with an ultrasound probe
CN102821679B (zh) 2010-02-02 2016-04-27 C·R·巴德股份有限公司 用于导管导航和末端定位的装置和方法
ES2778041T3 (es) 2010-05-28 2020-08-07 Bard Inc C R Aparato para su uso con sistema de guiado de inserción de aguja
CA2806353A1 (en) 2010-08-09 2012-02-16 C.R. Bard Inc. Support and cover structures for an ultrasound probe head
US20120046562A1 (en) 2010-08-20 2012-02-23 C. R. Bard, Inc. Reconfirmation of ecg-assisted catheter tip placement
ES2541485T3 (es) * 2010-10-19 2015-07-21 Parenteral, A.S. Composición para el tratamiento de enfermedades inflamatorias, la cual comprende ácidos boswéllicos y cannabidiol
EP2632360A4 (en) 2010-10-29 2014-05-21 Bard Inc C R IMPROVED ASSISTED BY BIO-IMPEDANCE OF A MEDICAL DEVICE
US12318420B2 (en) 2010-12-01 2025-06-03 Gowey Research Group, Pllc Herbal formulations of carnivorous plants and methods for treating inflammation
US11344505B1 (en) * 2010-12-01 2022-05-31 Gowey Research Group, Pllc Herbal formulations of carnivorous plants and methods for treating inflammation
US12606824B2 (en) 2010-12-01 2026-04-21 Gowey Research Group, Pllc Micro-RNA profiling, compositions, and methods of treating diseases
US9566341B1 (en) 2011-04-27 2017-02-14 University Of Kentucky Research Foundation Compounds including Cox inhibitor moiety and enhanced delivery of active drugs using same
CA2835890A1 (en) 2011-07-06 2013-01-10 C.R. Bard, Inc. Needle length determination and calibration for insertion guidance system
USD724745S1 (en) 2011-08-09 2015-03-17 C. R. Bard, Inc. Cap for an ultrasound probe
USD699359S1 (en) 2011-08-09 2014-02-11 C. R. Bard, Inc. Ultrasound probe head
JP5820206B2 (ja) * 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
JP5820207B2 (ja) * 2011-09-13 2015-11-24 日東電工株式会社 経皮吸収促進用組成物および貼付製剤
WO2013070775A1 (en) 2011-11-07 2013-05-16 C.R. Bard, Inc Ruggedized ultrasound hydrogel insert
EP2861153A4 (en) 2012-06-15 2016-10-19 Bard Inc C R APPARATUS AND METHODS FOR DETECTION OF A REMOVABLE CAP ON AN ULTRASONIC PROBE
US10792318B2 (en) 2013-03-14 2020-10-06 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
ES2538335T3 (es) * 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
WO2016187722A1 (en) * 2015-05-27 2016-12-01 Mary Lynch Use of cannabinoids in the treatment of ocular inflammation and/or pain
WO2015074137A1 (en) 2013-11-20 2015-05-28 Mary Lynch Compositions and methods for treatment of ocular inflammation and pain
WO2015120256A2 (en) 2014-02-06 2015-08-13 C.R. Bard, Inc. Systems and methods for guidance and placement of an intravascular device
US11331279B2 (en) 2014-05-29 2022-05-17 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
US12544389B2 (en) 2014-05-29 2026-02-10 Fresh Cut Development, Llc Stable cannabinoid formulations
US11911361B2 (en) 2014-05-29 2024-02-27 Radius Pharmaceuticals, Inc. Stable cannabinoid formulations
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
EP3160445B1 (en) * 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Mdi related products and methods of use
WO2016011451A1 (en) * 2014-07-18 2016-01-21 Medipath, Inc. Compositions and methods for physiological delivery using cannabidiol
CN106794168A (zh) * 2014-07-21 2017-05-31 格利亚有限责任公司 用大麻素治疗放疗和化疗相关的认知或情感损伤的方法
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
US10398776B1 (en) * 2014-11-03 2019-09-03 Essential Green Goodness LLC Phonophoretic cannabidiol composition and transdermal delivery system
US20170367875A1 (en) * 2014-12-17 2017-12-28 One World Cannabis Ltd Novel condom comprising cannabis derived compositions for enhancement of sexual pleasure and decrease of erectile dysfunction symptoms
EP3232808B1 (de) * 2014-12-19 2020-04-01 THC Pharm GmbH The Health Concept Cbd-haltiges getränk
MA41299A (fr) * 2014-12-30 2017-11-07 Axim Biotechnologies Inc Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite
US10973584B2 (en) 2015-01-19 2021-04-13 Bard Access Systems, Inc. Device and method for vascular access
BR112017018944A2 (en) * 2015-03-02 2018-05-15 Afgin Pharma, Llc method of treating a disease state or condition in humans with a carbinoid drug, and method of treating a disease state or condition in a mammal other than a human with carbinoid drug (s)
DK3302437T4 (da) * 2015-05-28 2026-02-23 Fresh Cut Dev Llc Stabile cannabinoidformuleringer
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
US10349890B2 (en) 2015-06-26 2019-07-16 C. R. Bard, Inc. Connector interface for ECG-based catheter positioning system
GB2542797A (en) * 2015-09-29 2017-04-05 Gw Pharma Ltd Use of cannabinoids in the treatment of inflammatory skin diseases
GB2544468A (en) * 2015-11-12 2017-05-24 Jaytee Biosciences Ltd Liquid formulation
US11000207B2 (en) 2016-01-29 2021-05-11 C. R. Bard, Inc. Multiple coil system for tracking a medical device
CN109069475B (zh) 2016-04-22 2022-01-28 受体控股公司 快速作用植物类医药化合物和营养补剂
US12409152B2 (en) * 2019-08-30 2025-09-09 Natural Extraction Systems, LLC Compositions and methods related to dissolved oxides
KR102295739B1 (ko) 2016-05-03 2021-08-30 뉴마 레스퍼러토리 인코포레이티드 유체들의 폐기관계로의 전달을 위한 액적 전달 디바이스 및 사용 방법
US20190184364A1 (en) * 2016-05-03 2019-06-20 International Flavors & Fragrances Inc. Fragrance compositions containing microcapsules
JP7054691B2 (ja) 2016-05-04 2022-04-14 インメド ファーマシューティカルズ インコーポレイティド 表皮水疱症及び関連する結合組織疾患の治療におけるカンナビノイドの局所製剤の使用
US20190030170A1 (en) * 2016-05-10 2019-01-31 Vireo Health LLC Cannabinoid formulations with improved solubility
JP7225103B2 (ja) 2016-10-11 2023-02-20 ジービーエス グローバル バイオファーマ,インコーポレイテッド 神経変性疾患を処置するためのカンナビノイド含有複合混合物
WO2018083697A1 (en) * 2016-11-02 2018-05-11 To Pharmaceuticals Llc Combination therapy of cbd and copaxone
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
JP7225104B2 (ja) 2017-02-01 2023-02-20 ジービーエス グローバル バイオファーマ,インコーポレイテッド マスト細胞関連炎症障害又は好塩基球媒介炎症障害の治療のためのカンナビノイド含有複合混合物
AU2018221881B2 (en) * 2017-02-15 2023-09-14 Botanix Pharmaceuticals Ltd Formulations of cannabinoids for the treatment of acne
US10231948B2 (en) 2017-02-27 2019-03-19 Jason Ty Nguyen Metered dose inhaler compositions, systems, and methods
GB201706969D0 (en) * 2017-05-02 2017-06-14 Medherant Ltd Formulation
GB2564383B (en) 2017-06-23 2021-04-21 Gw Res Ltd Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
WO2019018705A1 (en) * 2017-07-21 2019-01-24 Masaya World, Llc CAPRYLIC ACID ENRICHED IN CANNABIDIOL
WO2019034936A2 (en) * 2017-08-13 2019-02-21 Buzzelet Development And Technologies Ltd TERPENE ENRICHED CANNABINOID COMPOSITION AND PROCESSING METHOD
JP2020530857A (ja) * 2017-08-14 2020-10-29 ジナーバ・ファーマシューティカルズ・インコーポレイテッド 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
CN109498606A (zh) * 2017-09-15 2019-03-22 汉义生物科技(北京)有限公司 一种含有大麻二酚和/或次大麻二酚的组合物及其在治疗痛经中的应用
JOP20200045A1 (ar) 2017-09-19 2020-02-27 Zynerba Pharmaceuticals Inc كانابيدْيُول تخليقي يتم تناوله عبر الأدمة لعلاج الصرع البؤري لدى البالغين
US12357604B2 (en) 2017-09-22 2025-07-15 Inmed Pharmaceuticals Inc. Topical formulations of cannabinoids and use thereof in the treatment of pain
US10220061B1 (en) 2017-09-26 2019-03-05 Cynthia Denapoli Method of reducing stress and anxiety in equines
CA3300266A1 (en) 2017-09-28 2026-03-02 Harmony Biosciences Management, Inc. Treatment of fragile x syndrome with cannabidiol
CN118203735A (zh) 2017-10-04 2024-06-18 精呼吸股份有限公司 电子呼吸致动式直线型液滴输送装置及其使用方法
CN111801093A (zh) * 2017-10-17 2020-10-20 雷米生物科学公司 用于包括cbd增强的组合物、制剂和嵌合体的部分的改善的递送系统
CA3082192A1 (en) 2017-11-08 2019-05-16 Pneuma Respiratory, Inc. Electronic breath actuated in-line droplet delivery device with small volume ampoule and methods of use
KR102063524B1 (ko) * 2017-11-10 2020-01-08 안용훈 칸나비디올을 포함하는 화장료 조성물
GB2568929A (en) 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
GB201720992D0 (en) * 2017-12-15 2018-01-31 Hooper Mark A medical use
BR112020014911A2 (pt) * 2018-01-24 2020-12-08 Botanix Pharmaceuticals Ltd Regime de dosagem de canabinoide para dermatite e condições de pele inflamatórias
AU2019211468B2 (en) * 2018-01-24 2024-05-02 Botanix Pharmaceuticals Ltd Cannabinoid dosing regime for acne
AU2019210704A1 (en) * 2018-01-24 2020-08-06 Botanix Pharmaceuticals Ltd Cannabinoid dosing regime for psoriasis
CN112752556A (zh) * 2018-04-27 2021-05-04 雷米生物科学公司 新的医疗装置、递送运载体及其制造
GB201806953D0 (en) 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations
US11096904B2 (en) 2018-05-11 2021-08-24 Linda J. Kaplan Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia
US12576045B2 (en) 2018-05-11 2026-03-17 Kaplan Ip, Llc Methods and nutraceutical compositions for the prevention and/or mitigation of veisalgia
US20200009077A1 (en) * 2018-07-03 2020-01-09 TRUETIVA, Inc. Compositions for treating dermatological diseases
US10588979B1 (en) * 2018-09-17 2020-03-17 Cody D. Freeze Cannabinoid and terpene-infused topical cream
CN112867443B (zh) 2018-10-16 2024-04-26 巴德阿克塞斯系统股份有限公司 用于建立电连接的安全装备连接系统及其方法
US12303487B2 (en) 2018-11-19 2025-05-20 Spoke Sciences, Inc. N-acylated fatty amino acids to reduce absorption variability in cannabinoid based compositions
IL325123A (en) 2018-12-14 2026-02-01 Harmony Biosciences Man Inc Treating 22q11.2 Deficiency Syndrome with Cannabidiol
JP2022512409A (ja) 2018-12-14 2022-02-03 ナチュラル イクストゥラクション システムズ,エルエルシー アニオン性カンナビノイド分子と関連する組成物および方法
US20220071922A1 (en) * 2018-12-26 2022-03-10 Clear Lake Research, Llc Delivery of health benefits through component formulation
US12544101B2 (en) 2019-01-30 2026-02-10 Bard Access Systems, Inc. Systems and methods for tracking medical devices
CN113544117A (zh) * 2019-02-06 2021-10-22 埃默拉尔德健康制药公司 大麻二酚衍生物的调配物和其作为2型大麻素受体(cb2)的调节剂的用途
IT201900003325A1 (it) * 2019-03-07 2020-09-07 C I A M S R L Composizione per la prevenzione e trattamento della dermatite atopica
US20230414492A1 (en) * 2019-04-02 2023-12-28 Nose To Brain Therapeutics Llc Intranasal delivery of cannabidiol to treat central nervous system disorders
WO2020206205A1 (en) * 2019-04-03 2020-10-08 Willow Bark Brands, Inc Dosage forms and methods of preparation and use thereof
US11806645B1 (en) 2019-05-07 2023-11-07 Cannaceutical Extractions LLC Methods of producing CBD/THC oils
US11931333B1 (en) * 2019-05-28 2024-03-19 Peter Van Horn Topical treatment of herpes infections
US12029707B2 (en) 2019-05-28 2024-07-09 Tech Swerve Llc Penetrating topical pain relief compositions and methods of use
EP3975703A4 (en) 2019-05-28 2023-07-12 Tech Swerve LLC PENETRATING TOPICAL PAIN RELIEF COMPOSITIONS AND METHOD OF USE
US20220296535A1 (en) * 2019-06-18 2022-09-22 Botanix Pharmaceuticals Limited Antibacterial Dosage Regime Using Cannabinoids
EP4512472A3 (en) * 2019-08-05 2025-04-30 CS Medica A/S Topical formulations comprising cannabidiol, method of preparing the composition and use thereof
US12653782B2 (en) 2019-09-12 2026-06-16 Nulixir Inc. Controlled release concentrate and suspensions including the same
WO2021055499A1 (en) 2019-09-17 2021-03-25 Zynerba Pharmaceuticals, Inc. Treatment of behavioral impairment in developmental and epileptic encephalopathy
US12409131B2 (en) 2019-10-03 2025-09-09 Pike Therapeutics Usa, Inc. Transdermal delivery of dronabinol
CN114650809A (zh) 2019-10-03 2022-06-21 斯塔顿治疗公司 屈大麻酚的透皮递送
US12016829B2 (en) * 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
US12186280B2 (en) 2019-10-11 2025-01-07 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
EP4725549A3 (en) 2019-10-13 2026-06-10 FibroBiologics, Inc. Cannabidiol adjuvant therapy for treatment of disc degenerative disease
US12121617B2 (en) 2019-10-14 2024-10-22 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
JP2022551730A (ja) * 2019-10-14 2022-12-13 パイク セラピューティクス,インコーポレイテッド カンナビジオールの経皮送達
US12268699B2 (en) 2019-10-14 2025-04-08 Pike Therapeutics Inc. Transdermal delivery of tetrahydrocannabinol
US12533324B2 (en) * 2019-10-31 2026-01-27 Natural Extraction Systems, LLC Compositions and methods related to organic oxides
CA3166011A1 (en) * 2019-12-31 2021-07-08 Soluscience, Llc Water-soluble cannabinoid formulations and methods of their making
WO2021150595A1 (en) * 2020-01-20 2021-07-29 Nutramax Laboratories, Inc. Novel formulations comprising cannabis
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
US20210346310A1 (en) * 2020-04-20 2021-11-11 Pike Therapeutics, Inc. Transdermal and/or topical, pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic pain
EP4153154A4 (en) 2020-05-21 2024-08-07 Elementis Specialties, Inc. Cannabidiol and active delivery systems
JP7856584B2 (ja) 2020-05-26 2026-05-11 ハーモニー・バイオサイエンシズ・マネージメント・インコーポレイテッド カンナビジオールを用いた自閉症スペクトラム障害の処置
GB202009321D0 (en) 2020-06-18 2020-08-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
TWI902836B (zh) 2020-06-29 2025-11-01 美商和諧生物科學管理股份有限公司 以大麻二酚(cannabidiol)治療X染色體脆折症候群
WO2022003623A1 (en) * 2020-07-01 2022-01-06 Pike Therapeutics, Inc. Transdermal pharmaceutical formulations for the treatment of multiple sclerosis
US20230131989A1 (en) * 2020-07-29 2023-04-27 Medterra Pharma Llc Cannabinoid compositions and methods of using for the treatment of non-eosinophilic inflammation and inflammatory disorders
WO2022026960A1 (en) 2020-07-31 2022-02-03 Natural Extraction Systems, LLC Compositions and methods related to excipients and cannabinoid formulations
GB202012836D0 (en) * 2020-08-17 2020-09-30 Futura Medical Developments Ltd Topical composition
JP2023542474A (ja) * 2020-08-21 2023-10-10 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 防腐剤系およびそれを含む組成物
EP4243774A4 (en) 2020-11-16 2024-11-06 Synergy Life Science, Inc. Cannabinoid emulsifier
AU2021392090A1 (en) 2020-12-03 2023-07-06 Harmony Biosciences Management, Inc. Cannabidiol for the treatment of refractory seizures
MX2023006561A (es) * 2020-12-03 2023-07-06 Pike Therapeutics Inc Formulaciones farmaceuticas transdermicas que comprenden cbd o thc para el tratamiento del cancer.
US20240307418A1 (en) 2021-01-28 2024-09-19 Zynerba Pharmaceuticals, Inc. Treatment of sleep apnea with cbd
CA3207330A1 (en) 2021-02-05 2022-08-11 Lone HENRIKSEN Supplement for arthritis and psoriasis
WO2022173789A1 (en) * 2021-02-10 2022-08-18 Natural Extraction Systems, LLC Cannabigerol and cannabigerol derivatives for use to treat health conditions in humans
WO2022215030A1 (en) * 2021-04-08 2022-10-13 Pike Therapeutics Inc., 1219014 B.C. Ltd Pharmaceutical composition and method for treating seizure disorders
AU2022257344A1 (en) * 2021-04-12 2023-10-26 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
AU2022260813A1 (en) * 2021-04-22 2023-10-26 Pike Therapeutics Inc. Transdermal pharmaceutical formulations for the treatment of chronic pain
DK181458B1 (en) * 2021-05-06 2024-01-31 Cs Medica As Wound treatment composition, use thereof and method for providing said composition
DK181405B1 (en) * 2021-05-25 2023-10-17 Cs Medica As Gel for Intranasal Application, its Provision and Use
WO2022271848A1 (en) 2021-06-22 2022-12-29 Pneuma Respiratory, Inc. Droplet delivery device with push ejection
US12064461B2 (en) * 2021-07-16 2024-08-20 Avicanna Inc. Deep penetrating topical cannabinoid compositions and methods for treating musculoskeletal inflammation and pain
CA3234880A1 (en) * 2021-10-13 2023-04-20 Pneuma Respiratory, Inc. Compositions for delivery of cannabinoids
CN118284412A (zh) 2021-10-22 2024-07-02 Zyne制药公司 伴中度至重度焦虑和/或社交回避的自闭症谱系障碍受试者易怒症的治疗
WO2023076931A2 (en) 2021-10-26 2023-05-04 Ecofibre Limited Systems and methods for producing hemp extracts and compositions
CA3235080A1 (en) 2021-10-26 2023-04-05 Alexandra M CAPANO Methods of treating endometriosis and other non-cancer gynecological disorders with hemp extract
KR20240121723A (ko) 2021-10-26 2024-08-09 에코파이버 유에스에이 인코포레이티드 대마 추출물을 사용하여 자궁내막암을 치료하는 방법
CA3235075A1 (en) 2021-10-26 2023-05-04 Ecofibre USA Inc. Methods of treating head and neck cancers with hemp extract
CN116327738A (zh) * 2021-12-22 2023-06-27 宝泓生医股份有限公司 含有大麻二酚的贴剂
US20230404910A1 (en) * 2022-06-16 2023-12-21 Stephanie Gore Implantable cannabis transdermal
CN119768202A (zh) 2022-07-18 2025-04-04 精呼吸股份有限公司 小步长高分辨率气溶胶生成系统及方法
AU2023367739A1 (en) 2022-10-26 2025-06-12 Dove Innovation Pty Limited Stabilized compositions comprising cannabidiol
EP4608425A1 (en) 2022-10-26 2025-09-03 Ecofibre USA Inc. Methods of treating estrogen sensitive diseases with cannabis extract
WO2024158861A1 (en) * 2023-01-24 2024-08-02 Actual Natural Health & Wellness Products, Inc. Nasal hygiene method and composition
AU2024267304A1 (en) * 2023-05-11 2026-01-08 Spiritus Bioscience, Inc. Sublingual spray formulations of psychedelics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
WO2009020666A1 (en) * 2007-08-06 2009-02-12 Insys Therapeutics Inc. Oral cannabinoid liquid formulations and methods of treatment
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use

Similar Documents

Publication Publication Date Title
JP2011026329A5 (enExample)
JP2011006413A5 (enExample)
JP2012524113A5 (enExample)
JP2011093937A5 (enExample)
JP2013539946A5 (enExample)
JP2011214087A5 (enExample)
JP2013531034A5 (enExample)
JP2013531018A5 (enExample)
JP2012031285A5 (enExample)
JP2014505137A5 (enExample)
JP2012011657A5 (enExample)
JP2013064178A5 (enExample)
JP2011208181A5 (enExample)
JP2010166925A5 (enExample)
JP2012042569A5 (enExample)
JP2010037339A5 (enExample)
JP2012011658A5 (enExample)
JP2011207949A5 (enExample)
JP2012193264A5 (enExample)
JP2011146571A5 (enExample)
JP2012190699A5 (enExample)
JP2013503915A5 (enExample)
JP2011233516A5 (enExample)
JP2010211056A5 (enExample)
JP2010196033A5 (enExample)